US nuclear medicine funds slashed

President's 2006 budget would cut such spending at DOE by two thirds

Written byJohn Dudley Miller
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Proposed cuts in the 2006 US Federal budget would wipe out nearly two thirds of the Department of Energy's (DOE's) support for nuclear medicine research, a 50-year-old program that has helped produce positron emission tomography and thallium scanning technology.

The president's proposed budget would cut this year's $37.9 million in funding to $13.7 million next year. All or part of the remaining funding might be cut in the fiscal year (FY) 2007 budget, but that decision has not yet been made, according to spokespeople. Among other projects, DOE funding now supports research on early breast cancer detection based on gene expression and how nicotine alters the brain.

Office of Management and Budget (OMB) spokesperson Noam Neusner said nuclear medicine research is being cut because it doesn't advance DOE's "core mission, which is energy and energy resource programs, not medical research."

Neusner said that the National Institutes of Health (NIH) would ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA